Purpose-Built for Government Collaboration.
A Public Benefit Corporation
Built to Serve.
As a certified B Corp and Public Benefit Corporation, our core focus is on stocking and protecting America’s medicine cabinet. We work in partnership with U.S. government agencies, such as the Biomedical Advanced Research and Development Authority (BARDA), the HHS Administration for Strategic Preparedness and Response (ASPR), and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), to ensure a more secure, sustainable, and accessible supply of the medicines our nation depends on.
Our mission is to help brilliant minds, including our partners in the government, bring medicines to life while reducing overreliance on fragile global supply chains and legacy manufacturing models.
Strengthening National Preparedness.
Phlow was founded to help close a critical gap in America’s ability to respond to public health emergencies by securing access to essential medicines, medical countermeasures, and their ingredients for Americans and our armed forces.
We’ve built and operate state-of-the-art facilities on U.S. soil. Our infrastructure supports the full spectrum of small molecule API manufacturing, from early-stage development and commercial-scale production to the storage of critical APIs for quick conversion through our Strategic Active Pharmaceutical Ingredient Reserve (SAPIR™) program. This infrastructure was built well in advance of its time, saving American taxpayers billions of dollars.
To date, Phlow has delivered more than 2 million doses of essential medicines to the Strategic National Stockpile (SNS), directly supporting our Nation’s emergency response readiness.
Meeting Public Health and National Security Challenges with Speed and Certainty.
We understand the stakes and the urgency. Whether it’s preparing for future pandemics, responding to natural disasters, ensuring our warfighters in the U.S. Armed Forces are well-equipped for battle, or addressing long-standing medicine shortages, Phlow delivers:
- Expertise in building a domestic supply chain
- Domestic infrastructure that strengthens supply chain resilience
- Advanced, tech-enabled process development and flow chemistry capabilities
- Dedicated project management with full regulatory and quality integration
- Immediate scale-up capacity
- SAPIRâ„¢ program for essential medicines and medical countermeasures
A Domestic API Pipeline
Securing our Nation’s Essential Medicines Supply.
Phlow is building a resilient, U.S.-based pipeline of small molecule APIs for our Nation’s most essential medicines. Focused on reducing foreign dependence and enhancing preparedness, these formulation-ready ingredients are developed with advanced technologies and ready to be converted to finished medicines when they’re needed most.
Labetalol Hydrochloride*
Succinylcholine Chloride, USP
Ciprofloxacin Hydrochloride, USP
Epinephrine
P-0004-NO
P-00013-AT
P-0005-FR
P-0009-OD
P-0010-KT
P-0011-LO
P-0006-AL
P-0007-MD
P-0008-NA
P-000012-PR
*DMF filed on behalf of Phlow and in partnership with AMPAC Fine Chemicals – an SK Pharmteco Company.